Ranbaxy News
Most Popular Ranbaxy Story
Ranbaxy, FDA enter consent decree over GMP, data breaches
Plans for the $500 million that Daiichi Sankyo set aside to get problem child Ranbaxy out of regulatory jail became clearer Wednesday with the filing of a consent decree. The Indian-based drugmaker Read more...
Latest Headlines
- January 26, 2012
- January 16, 2012
- January 3, 2012
- December 21, 2011
- December 1, 2011
- November 28, 2011
- October 17, 2011
- September 14, 2011
- September 4, 2011
- December 6, 2010
- September 6, 2010
- September 6, 2010
- August 30, 2010
- May 31, 2010
- March 15, 2010
- February 17, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
